GW is hiring

Discussion in 'Lundbeck' started by anonymous, Apr 25, 2018 at 6:37 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Good comeback psych boy! Dumbass.
     

  2. anonymous

    anonymous Guest

    If anyone gets live interview in Midwest with ML be careful... not a great guy to work for
     
  3. anonymous

    anonymous Guest

    Thanks but can you tell us more? Where did he come from? Just a bit more info please
     
  4. anonymous

    anonymous Guest

    UCB can I say more
     
  5. anonymous

    anonymous Guest


    Yes pleases say more. Is he as bad as the one post insinuates?
     
  6. anonymous

    anonymous Guest

    Novartis Neuro and Teva are expanding to launch new products. Check out their open positions. Good luck!
     
  7. anonymous

    anonymous Guest

    Not sure I would run to either of these companies. Both are a hot mess.
     
  8. anonymous

    anonymous Guest

    Novo will be fine, but Teva is being run by Kare the Cutter, and is in shambles. All he knows how to do is fire people. Novo may actually be the company to first announce a cure for diabetes using stem cells. So, compare it to Lundbeck's wonderful pipeline, and I'm sure the winner will be Novo. Nobody has ever even heard of 35700. And the deal with faster processing speed won't impress anyone unless you cn show where there is a clear cut meaningful benefit to patients, and we can't. Time for another patient profile from Max and friends! Unbelievable.
     
  9. anonymous

    anonymous Guest

    I’d go to Lundbeck before Teva and THAT is saying something.

    Those 2 companies top my list of companies with the worst future prospects, but at least Lundbeck is foundation owned which protects them from takeover despite thier complete lack of innovative or valuable assets post Onfi.

    Teva is in firesale mode and will be exiting branded market as they no longer have an R&D organization.

    Novartis is getting bad PR at the moment, but is poised to survive and launch new products.
     
  10. anonymous

    anonymous Guest

    It's Novartis not Novo Nordisk idiot